PDLIM7 and diffuse large B-cell lymphoma: Recent work by Mangiaterra et al. demonstrated that highly sensitive methods can detect EBV transcripts (LMP1 and/or EBNA2) in cases previously considered EBV-negative by conventional approaches, identifying viral material in 29.17% of diffuse large B-cell lymphoma cases originally classified as EBV-negative [18].